Silexion’s abstract will be published on the ASCO Gastrointestinal Cancers Symposium website at 5:00 p.m. ET on January 21, 2025. Following the presentation, the poster will be available on Silexion ...

Silexion to present SIL-204 data at leading Cancer Symposium designed to feature the latest science in the field of GI cancers Cayman Islands, January 13, 2025 -- Silexion Therapeutics Corp. (NASDAQ: ...

(RTTNews) - Silexion Therapeutics Corp. (SLXN), a clinical-stage biotechnology company, announced Tuesday significant preclinical data ... model. Silexion's new formulation of SIL-204 ...

Car Deal of the Day: Skoda Octavia vRS Estate is practical, hot-hatch quick and only £284 per month Car Deal of the Day: Skoda Octavia vRS Estate is practical, hot-hatch quick and only £284 per ...

Auxiliary input socket DAB Digital radio JBL Premium sound system with 14 speakers Steering wheel mounted audio/telephone controls USB connection WLTP - CO2 (g/km) - Comb 250 WLTP - CO2 (g/km ...

Malaysia's data center sector maintains an optimistic outlook despite new US export restrictions on artificial intelligence (AI) chips, which were implemented in the final days of President Joe ...

New preclinical findings provide validation for Silexion’s new systemic administration approach for SIL-204, demonstrating inhibition of tumor growth in a clinically relevant orthotopic model ...

The fund, which combines a BTC base position with two uncorrelated strategies, achieved an impressive return of 204% in 2024 ... AI-based forecasting model to create a dollar-neutral portfolio ...

Silexion’s latest data highlights SIL-204’s ability to enhance first-line therapies, showcasing its potential to transform outcomes in these hard-to-treat cancers. NEW YORK, January 16 ...

Most stock quote data provided by BATS. US market indices are shown in real time, except for the S&P 500 which is refreshed every two minutes. All times are ET. Factset: FactSet Research Systems ...